In summary, this study identifies SYDE1 as an oncogene in gliomas that can regulate the proliferation and migration of glioma cells and is predicted to interact with the SNHG16/hsa-miR-520e axis. The gene discussed is SNHG16; the disease is central nervous system cancer.